MBRX
Moleculin Biotech, Inc.Company with tickers: MBRX
CIK
1659617
CUSIP
60855D408
Shares Outstanding
5,336,350
13F Activity (30d)
18 filings
18 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $0 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $7,874,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $5,378,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-7,874,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-12,845,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-3.54 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | — |